Background The causes, optimal treatments, and medical/psychosocial sequelae of breast
cancer in men are poorly understood. Design A systematic review of the English language …

Male breast cancer (MBC) is a rare disease, accounting for less than 1% of all breast cancer
diagnoses worldwide. Although breast carcinomas share certain characteristics in both …

Patients with breast cancer (BC) with low levels of human epidermal growth factor receptor 2
(HER2) expression (HER2-low) could benefit from novel antibody–drug conjugates …

Male breast cancer accounts for around 1% of all breast cancer cases, but the incidence has
increased over the past 25years. The rarity of this entity precludes prospective randomized …

Molecular subtyping of breast cancer by gene expression has proven its significance in
females. Immunohistochemical surrogates have been used for this classification, because …

Male breast cancer remains understudied despite evidence of rising incidence. Using a co-
ordinated multi-centre approach, we present the first large scale biomarker study to define …

Although similar phenotypically, there is evidence that male and female breast cancer differ
in their molecular landscapes. In this systematic review, we consolidated all existing …

Introduction Male breast cancer (MBC) is a rare and inadequately characterized disease.
The aim of the present study was to characterize MBC tumors transcriptionally, to classify …

It has become customary to extrapolate from the results of treatment trials for female
breastcancer and apply them to males with the disease. In the absence of results from …

Recently, the number of studies on male breast cancer (MBC) has been increasing.
However, as MBC is a rare disease there are difficulties to undertake studies to identify …